Spero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Ted Jenkins - Vice President, Investor Relations and Strategic Finance Sath Shukla - Chief Executive Officer Kamal Hamed - Chief Medical Officer Steve Dipalma - Interim Chief Financial Officer and Treasurer Conference Call Participants Louise Chen - Cantor Boobalan Pachaiyappan - H.C. Wainwright Ritu Baral - Cowen Operator Good afternoon and welcome to the Spero Therapeutics Second Quarter ...